Project Details
| Acronym | PHARE Group |
|---|---|
| Status | Active |
| Effective start/end date | 1/09/23 → … |
Attachment to an Research Institute in UNAMUR
- NARILIS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Bone Turnover in Postmenopausal Women: Evaluating the Impact of Estetrol (E4) from a Randomized Placebo-Controlled Phase 3 Trial
Douxfils, J., Black, A., Taziaux, M., Gaspard, U. J., Kapoor, E., Lobo, R. A., Utian, W. H. & Foidart, J.-M., 13 Apr 2025.Research output: Contribution to conference › Poster › peer-review
-
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project
Sharma, M., Beaudart, C., Clark, P., Fujiwara, S., Adachi, J. D., Papaioannou, A., Messina, O. D., Morin, S. N., Kohlmeier, L., Nogues, X., Leckie, C., Harvey, N. C., Kanis, J. A., Reginster, J. Y., Hiligsmann, M. & Silverman, S. L., Jan 2025, In: Osteoporosis International. 36, 1, p. 71-80 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Fezolinetant for VMS - a balanced view on efficacy and safety needed
Douxfils, J., Beaudart, C. & Dogné, J.-M., 2024, In: Climacteric. 27, 4, p. 435 1 p.Research output: Contribution to journal › Letter › peer-review
Activities
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
2 May 2025 → 6 May 2025Activity: Talk or presentation types › Oral presentation
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
13 Feb 2025Activity: Talk or presentation types › Oral presentation
-
Gender Equity in Osteoporosis Pharmacological Treatment: Evidence from a Recent Meta-Analysis
Beaudart, C. (Speaker)
20 Feb 2025Activity: Talk or presentation types › Invited talk